研究發展處

Neuroscience

1. Migraine 100%
2. Headache 67%
3. Functional Magnetic Resonance Imaging 63%
4. Functional Connectivity 62%
5. Alzheimer's Disease 60%
6. Cognitive Disorders 37%
7. Major Depressive Disorder 35%
8. Electroencephalogram 33%
9. Magnetic Resonance Imaging 33%
10. Magnetic Resonance Imaging 33%
11. Cognitive Function 31%
12. Gray Matter Volume 31%
13. Mild Cognitive Impairment 31%
14. Behavior (Neuroscience) 30%
15. Cerebrovascular Accident 30%
16. Hippocampus 28%
17. Parkinson's Disease 27%
18. In Vivo 24%
19. Brain Network 23%
20. Amygdala 22%
21. Diffusion Tensor Imaging 20%
22. Heart Rate Variability 20%
23. Default Mode Network 19%
24. Gray Matter 19%
25. Thalamus 19%
26. Blood Plasma 18%
27. Striatum 17%
28. Cerebellum 17%
29. Receptor 16%
30. Obstructive Sleep Apnea 16%
31. Comorbidity 14%
32. Gyri 14%
33. Cluster Headache 14%
34. Nociception 14%
35. Pervasive Developmental Disorder 14%
36. Glutamic Acid 13%
37. Antidepressant 13%
38. Mental Disorder 13%
39. Brain Ischemia 12%
40. Voxel-Based Morphometry 12%
41. Fractional Anisotropy 12%
42. Electrotherapy 12%
43. Magnetoencephalography 12%
44. Evoked Potential 12%
45. Frontal Lobe 12%
46. Neural Network 12%
47. Sleep Quality 12%
48. Longitudinal Study 11%
49. Tractography 11%
50. Gamma-Aminobutyric Acid 11%
51. Prefrontal Cortex 11%
52. Depressive Disorder 11%
53. Brain-Derived Neurotrophic Factor 11%
54. Attention Deficit Hyperactivity Disorder 11%
55. Treatment-Resistant Depression 11%
56. Fluorine-18 11%
57. Ketamine 10%
58. Neurodegenerative Disorder 10%
59. Orbitofrontal Cortex 10%
60. Dopaminergic 10%
61. Brain Areas 10%
62. Brain-Computer Interface 10%
63. Programmed Cell Death 10%
64. Fibromyalgia 10%
65. Putamen 10%
66. Amyloid Protein 10%
67. Metabolic Pathway 9%
68. Positron Emission Tomography 9%
69. Cingulate Cortex 9%
70. Posterior Cingulate 9%
71. Cerebral Cortex 9%
72. Subjective Cognitive Decline 9%
73. Cerebrovascular Disease 9%
74. Brain Age 9%
75. Motor Cortex 9%
76. Temporal Lobe 9%
77. Anterior Cingulate Cortex 9%
78. Brain Imaging 9%
79. Oxidative Stress 9%
80. Bipolar Disorder 9%
81. In Vitro 8%
82. Transcranial Magnetic Stimulation 8%
83. Executive Function 8%
84. Brain Disease 8%
85. Medication Overuse 8%
86. Resting-State Functional Connectivity 8%
87. Hypertension 8%
88. Corpus Callosum 8%
89. Autism 8%
90. Brain Development 8%
91. Neuronal Activity 8%
92. Gene Expression 8%
93. Nervous System Disorder 8%
94. Somatosensory Cortex 8%
95. Auras 8%
96. Stem Cell 8%
97. Epoxide Hydrolase 7%
98. Precuneus 7%
99. Interneuron 7%
100. Neural Stem Cell 7%

Keyphrases

1. Migraine 68%
2. Taiwan 57%
3. Alzheimer's Disease 49%
4. Functional Connectivity 40%
5. Chronic Migraine 37%
6. Major Depressive Disorder 33%
7. Functional Magnetic Resonance Imaging 33%
8. Electroencephalography 32%
9. Healthy Controls 31%
10. Taiwanese 31%
11. Schizophrenia 30%
12. Headache 30%
13. Gray Matter Volume 29%
14. Cognitive Function 29%
15. Cognitive Impairment 27%
16. Reversible Cerebral Vasoconstriction Syndrome 26%
17. Brain Regions 25%
18. Parkinson's Disease 23%
19. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 23%
20. Older Adults 23%
21. Mild Cognitive Impairment 22%
22. Magnetoencephalography 21%
23. Dementia 20%
24. Heart Rate Variability 19%
25. Migraine Patients 18%
26. Confidence Interval 18%
27. Hippocampus 18%
28. Brain-computer Interface 17%
29. Diffusion Tensor Imaging 17%
30. Cluster Headache 17%
31. Obstructive Sleep Apnea 17%
32. Magnetic Resonance Imaging 17%
33. Striatum 16%
34. Default Mode Network 16%
35. National Cohort Study 15%
36. Cognitive Decline 15%
37. Electroencephalogram 14%
38. Resting State 14%
39. Neuroimaging 13%
40. Treatment-resistant Depression 13%
41. Autism Spectrum Disorder 13%
42. Cerebellum 12%
43. Aging 12%
44. Subjective Cognitive Decline 12%
45. Intracranial Hypotension 12%
46. White Matter 12%
47. Attention Deficit Hyperactivity Disorder 12%
48. Odds Ratio 11%
49. Pathophysiology 11%
50. Voxel-based Morphometry 11%
51. Amygdala 11%
52. International Headache Society 11%
53. Comorbidity 11%
54. Fractional Anisotropy 11%
55. Mini-Mental State Examination 11%
56. Brain Networks 11%
57. Human Brain 10%
58. Ketamine 10%
59. Neurodegenerative Diseases 10%
60. Brain Structure 10%
61. Brain Aging 10%
62. Brain Activity 10%
63. Brain Connectivity 10%
64. Age-related 10%
65. Primary Dysmenorrhea 10%
66. Episodic Migraine 10%
67. Oxidative Stress 10%
68. Single nucleotide Polymorphism 9%
69. Bipolar Disorder 9%
70. Resting-state Functional Connectivity (rs-FC) 9%
71. Fibromyalgia 9%
72. Healthy Adults 9%
73. Randomized Controlled Trial 9%
74. Positron Emission Tomography 9%
75. Sleep Quality 9%
76. Motor Cortex 9%
77. CISD2 9%
78. Neural Correlates 9%
79. Striatal 8%
80. Metabolic Syndrome 8%
81. Menstrual Pain 8%
82. Protein Kinase 8%
83. Neuroinflammation 8%
84. Proteomic Analysis 8%
85. Migraine Treatment 8%
86. Inflammation 8%
87. Ischemic Stroke 8%
88. Anterior Cingulate Cortex 8%
89. Hazard Ratio 8%
90. Apoptosis 8%
91. Medication Overuse Headache 8%
92. Antidepressants 8%
93. Cortex 8%
94. Cortical Neurons 8%
95. Steady-state Visual Evoked Potential (SSVEP) 8%
96. White Matter Hyperintensities 8%
97. Schizophrenic Patients 8%
98. Sex Differences 8%
99. Taiwan Biobank 8%
100. Cognitive Performance 8%